|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,031.00 GBX | 0.00% |
|
-0.34% | +11.32% |
| 03-13 | GSK and Amgen to add medicines to TrumpRx, Fox Business reports | RE |
| 03-13 | GSK plc Announces Expansion of AREXVY Approval to Adults Aged 18 to 49 Years for RSV Prevention | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GSK PLC | Other Pharmaceuticals | 0.00% | -0.34% | +11.32% | +34.41% | +28.97% | 108B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- GSK Stock
- Charts GSK plc
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition